Elena Garal-Pantaler

Publications

Ding Bo, Pignot Marc, Garal-Pantaler Elena, Villinger Beate, Desta Barnabas, Schmidt Katharina, Golam Sarowar, Stirnadel-Farrant Heide, Schwarting Andreas, Clinical Characteristics, Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany Ann. Rheum. Dis. - EULAR 2022 Annual European Congress of Rheumatology, June 1–4. 2022;

N Hunnicutt Jake, Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Georgiou Mary Elizabeth, Gairy Kerry, Prevalence of lupus nephritis among patients with systemic lupus erythematosus in Germany Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_3, May. 2022; 10.1093/ndt/gfac071.036.

Ding Bo, Pignot Marc, Garal-Pantaler Elena, Villinger Beate, Desta Barnabas, Golam Sarowar, Stirnadel-Farrant Heide, Marinoska Tatjana, Schefzyk Sebastian, Schwarting Andreas, Corticosteroid Use in Patients With Systemic Lupus Erythematosus in Germany: The CHAMOMILE Claims Database Study. DGRh 2022, Berlin, Germany 31 August–3 September. 2022;

Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Carnarius H., Gairy Kerry, Levy R., Economic Burden of Organ Damage in Systemic Lupus Erythematosus: Results From a German Claims Analysis. DGRh Kongress. 2021; 10.3205/21dgrh064.

Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Carnarius H., Levy R., Gairy Kerry, The Burden of Organ Damage Among Patients With Systemic Lupus Erythematosus in Germany. International Congress on Systemic Lupus Erythematosus. LUPUS & CORA 2021. 2021;

Schwarting Andreas, Friedel H., Garal-Pantaler Elena, Pignot Marc, Wang X., Nab H., Desta Barnabas, Hammond E. R., The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization. Rheumatol Ther.. 2021; 10.1007/s40744-021-00277-0.

Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Haller Hermann, Linssen Gerard C. M., Banerjee Amitava, Thuresson Marcus, Okami Suguru, Garal-Pantaler Elena, Overbeek Jetty, Mamza Jil Billy, Zhang Ruiqi, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes Obes Metab.. 2020; 22:1607–1618. 10.1111/dom.14074.

Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Haller Hermann, Linssen Gerard C. M., Banerjee Amitava, Thuresson Marcus, Okami Suguru, Garal-Pantaler Elena, Overbeek Jetty, Mamza Jil Billy, Zhang Ruiqi, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes Obes Metab.. 2020; 22:1607–1618. 10.1111/dom.14074.

Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Thuresson Marcus, Pignot Marc, Garal-Pantaler Elena, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study EASD Congress. 2019;

Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Thuresson Marcus, Pignot Marc, Garal-Pantaler Elena, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study European Association for the Study of Diabetes 55th Annual Meeting. 2019;

Schwarting Andreas, Friedel H., Garal-Pantaler Elena, Pignot Marc, Wang X., Nab H., Desta Barnabas, Hammond E. R., The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization. Rheumatol Ther. 2018; 10.1007/s40744-021-00277-0.

Hammond E. R., Friedel H., Garal-Pantaler Elena, Pignot Marc, Velthuis E., Wang X., Nab H., Desta Barnabas, Schwarting Andreas, Health Care Resource Use (HRU) and Medical Costs Analyses as a Function of Systemic Lupus Erythematosus (SLE) Disease Severity: Analysis of Claims Data of a German Sickness Fund. LUPUS. 2018; 5(Suppl 1): A1–A129. 10.1136/lupus-2018-abstract.204.

Hammond E. R., Friedel H., Garal-Pantaler Elena, Pignot Marc, Velthuis E., Wang X., Nab H., Desta Barnabas, Schwarting Andreas, Health Care Resource Utilisation (HCRU) and Cost Analyses of Systemic Lupus Erythematosus (SLE) as a Function of Disease Severity: Analysis of Real-World Claims Data from a German Sickness Fund. Ann. Rheum. Dis. 2018; 10.1136/annrheumdis-2018-eular.5150.